Fiercepharma.comNews Analysis

1

Following pharma's tariff trend, AbbVie unveils $10B US investment in 10 years

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

2

As J&J aims to 'fundamentally change' how bladder cancer type is treated, ImmunityBio plays defense

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

3

AstraZeneca's highly touted Truqap flunks another phase 3 trial

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

4

Abeona enters commercial gene therapy arena with FDA nod for Zevaskyn to treat rare genetic skin disease

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

5

PBMs call out big drugmakers for setting high drug prices in new digital ads

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

6

With industry's onshoring tide rolling on, Amgen blueprints $900M expansion at Ohio biomanufacturing plant

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

7

As pharma industry's reputation slips again, ViiV retains top spot among patient groups: survey

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

8

Novo moves past GLP-1 spat with Hims & Hers, tapping telehealth company to offer discounted Wegovy

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

9

Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

10

Pfizer, in sweeping cost cutting push, lifts overall savings target to $7.7B

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

11

Regeneron's Eylea franchise suffers double whammy with sales decline and surprise FDA rejection

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

12

Bayer gets industry discredit ruling overturned after accusation of ‘warming the market’ for Eylea launch

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

13

French health authorities suspend use of Valneva's chikungunya vaccine in older adults to probe 3 hospitalizations, one death

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

14

Roche moves to mitigate US tariff impact amid discussions with global governments

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

15

Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

Fiercepharma.com News

Trending Stories

Following pharma's tariff trend, AbbVie unveils $10B US investment in 10 years

As J&J aims to 'fundamentally change' how bladder cancer type is treated, ImmunityBio plays defense

AstraZeneca's highly touted Truqap flunks another phase 3 trial

Abeona enters commercial gene therapy arena with FDA nod for Zevaskyn to treat rare genetic skin disease

PBMs call out big drugmakers for setting high drug prices in new digital ads

With industry's onshoring tide rolling on, Amgen blueprints $900M expansion at Ohio biomanufacturing plant

As pharma industry's reputation slips again, ViiV retains top spot among patient groups: survey

Novo moves past GLP-1 spat with Hims & Hers, tapping telehealth company to offer discounted Wegovy

Texas outsourcer in Lilly's compounded tirzepatide lawsuit hit with FDA warning letter

Pfizer, in sweeping cost cutting push, lifts overall savings target to $7.7B

Regeneron's Eylea franchise suffers double whammy with sales decline and surprise FDA rejection

Bayer gets industry discredit ruling overturned after accusation of ‘warming the market’ for Eylea launch

French health authorities suspend use of Valneva's chikungunya vaccine in older adults to probe 3 hospitalizations, one death

Roche moves to mitigate US tariff impact amid discussions with global governments

Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe

Trending People

News Stories Published Over Time

Trending Topics

Most Popular Categories

Similar Websites

More Websites